DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / SHD Management, LLC
SHD Management, LLC
Institutional venture firmDallas, TXshdpartners.comSEC venture capital fund adviserone firm, 2 filing advisers
This firm files as 2 advisers on shdpartners.com: SHD Capital Management, LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
Early-stage MedTech Investors Formed in 2006, Scientific Health Development (SHD) is a venture capital firm based in Dallas, TX. SHD invests in early-stage medtech companies based in the U.S. that address unmet clinical needs in healthcare. Optimal companies are focused on easily adoptable technologies aimed at improving patient outcomes while minimizing overall economic burden. History…
venture manager, reported GAV $61M across 7 vehicles
Importance
30
moderate
Active deployment
30
moderate
Emerging
0
low
Completeness
81
high
Freshness
100
high
Research priority
10
low
Identity and regulatory footprint
- Headquarters
- Dallas, TXadviserinfo.sec.gov
- Office address
- 8144 WALNUT HILL LANE, SUITE 905, Dallas, TX, 75231adviserinfo.sec.gov
- Business phone
- 214-303-1540adviserinfo.sec.gov
- Website
- HTTP://SHDPARTNERS.COM
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 20, 2026
- Private funds reported
- 7 (7 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $60.9Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- info@shdpartners.comshdpartners.compublished by the subject
- business email
- 214-303-1540info@shdpartners.comshdpartners.compublished by the subject
- business phone
- 214-303-1540adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
17 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, medtech
- Stages
- early
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 82%Other Health Care 12%Other 6%
lead rate n/afollow-on rate n/anew logos, 12 months 17
Funds and vehicles
7 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| SHD Podimetrics, LLC | Fund | 2020 adv first reported | Mature | $2.8M Mar 26, 2024 | 12 | unknown | unknown |
| Scientific Health Development II, Ltd. | Fund | 2010 form d first sale | Harvest | $15.7M Mar 26, 2024 | 47 | $10.2M of $20.0M | Mar 2, 2010 |
| Scientific Health Development III, Ltd. | Fund | unknown | Unknown | $20.7M Mar 26, 2024 | 45 | unknown | unknown |
| Scientific Health Development, Ltd. | Fund | unknown | Unknown | $15.0M Mar 26, 2024 | 42 | unknown | unknown |
| SHD Encapsion Partners, LLC | Fund | unknown | Unknown | $3.5M Mar 26, 2024 | 12 | unknown | unknown |
| SHD II Co-Invest, LLC | SPV or co-invest vehicle | unknown | Unknown | $1.8M Mar 26, 2024 | 23 | unknown | unknown |
| SHD Anterios Partners, LLC | Fund | unknown | Unknown | $1.5M Mar 26, 2024 | 21 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
8 current, 1 departed
Andrew Offer
Founder or executiveChief Executive Officer · since Sep 1, 2020
Aoffer@shdpartners.com (published by the subject)FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Andrew Offer
General partnerCEO and General Partner
Aoffer@shdpartners.com (published by the subject)FactVenture organization websites (about, team, portfolio, thesis, news pages)
Phil Romano
General partnerCo-founder and General Partner
Stuart Fitts
General partnerCo-founder and General Partner
Mike Schotzinger
OtherPortfolio
JAY Stuart Fitts
PartnerManager · since Nov 1, 2010
Philip Romano
PartnerManager · since Nov 1, 2010
R. Michael Schotzinger
PrincipalPrincipal
Mike@shdpartners.com (published by the subject)FactVenture organization websites (about, team, portfolio, thesis, news pages)
1 departed (kept with end dates)
- Jordan Carter Meyer · Member · Nov 1, 2010 to Mar 26, 2024 Inference
Investments on record
17 edges, 17 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
8 relationships from shared deals, counted for the whole firm
OrbiMed 1 shared · one timeLongevity Venture Partners Management, LP 1 shared · one timeMutual Capital Partners Funds 1 shared · one timeMighty Capital Management LLC 1 shared · one timeMtvp Management, LLC 1 shared · one timeAperture Management LLC 1 shared · one timeInnovahealth Partners 1 shared · one timeSolas Bioventures Management, LLC 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
- Mar 26, 2024Jordan Carter Meyer (Member) no longer on Schedule A of SHD Management, LLC
- Mar 13, 2020SHD Podimetrics, LLC first reported on Form ADV by SHD Management, LLC (Venture Capital Fund), GAV $1,320,000Fund first reported on Form ADVFundsFactSHD Podimetrics, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 1, 2016Andrew Offer joined Schedule A of SHD Management, LLC as Chief Financial Officer
- Mar 20, 2015SHD Encapsion Partners, LLC first reported on Form ADV by SHD Management, LLC (Venture Capital Fund), GAV $3,450,000Fund first reported on Form ADVFundsFactSHD Encapsion Partners, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 20, 2015SHD Anterios Partners, LLC first reported on Form ADV by SHD Management, LLC (Venture Capital Fund), GAV $1,535,000Fund first reported on Form ADVFundsFactSHD Anterios Partners, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 20, 2015SHD Management, LLC first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 20, 2015Scientific Health Development III, Ltd. first reported on Form ADV by SHD Management, LLC (Venture Capital Fund), GAV $12,900,000Fund first reported on Form ADVFundsFactScientific Health Development III, Ltd.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 20, 2015SHD II Co-Invest, LLC first reported on Form ADV by SHD Management, LLC (Venture Capital Fund), GAV $1,800,000Fund first reported on Form ADVFundsFactSHD II Co-Invest, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 20, 2015Scientific Health Development II, Ltd. first reported on Form ADV by SHD Management, LLC (Venture Capital Fund), GAV $15,650,000Fund first reported on Form ADVFundsFactScientific Health Development II, Ltd.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 20, 2015Scientific Health Development, Ltd. first reported on Form ADV by SHD Management, LLC (Venture Capital Fund), GAV $15,000,000Fund first reported on Form ADVFundsFactScientific Health Development, Ltd.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $61M across 7 vehicles
- Sep 12, 2026Institutional venture firm (probable, 80%, cls-1)venture manager, reported GAV $61M across 7 vehicles
Evidence
53 observations from 3 sources